Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized open-label active-controlled trial of human growth hormone injection for short stature in children born small for gestational age
CTR20252083Phase 3Active
- Sponsor
- Anke Bio
- Start
- Aug 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of genotropin miniquick, somatropin in Short stature in children born small for gestational age, sponsored by Anke Bio. Started Aug 2025; status: active.
02
Drugs
genotropin miniquicksomatropin
03
Conditions
Short stature in children born small for gestational age
Beyond the preview
Go deeper on CTR20252083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252083.